CSPC Pharmaceutical’s goserelin sustained-release injection approved for China trial
CSPC Pharmaceutical Group says its goserelin sustained-release injection has received clinical trial approval in China.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
CSPC Pharmaceutical Group says its goserelin sustained-release injection has received clinical trial approval in China.